Specific immunotherapy of multiple myeloma patients using idiotype pulsed serum free generated dendritic cells.

被引：0
|
作者：
Reichardt, VL [1 ]
Milazzo, C [1 ]
Brugger, W [1 ]
Einsele, H [1 ]
Kanz, L [1 ]
Brossart, P [1 ]
机构：
[1] Univ Tubingen, Med Klin 2, Tubingen, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1594
引用
收藏
页码：378A / 379A
页数：2
相关论文
共 50 条
  • [31] Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation
    Bendandi, M
    Rodríguez-Calvillo, M
    Inogés, S
    de Cerio, ALD
    Pérez-Simón, JA
    Rodríguez-Caballero, A
    García-Montero, A
    Almeida, J
    Zabalegui, N
    Giraldo, P
    San Miguel, J
    Orfao, A
    LEUKEMIA & LYMPHOMA, 2006, 47 (01) : 29 - 37
  • [32] Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients
    Shinde, Prajakta
    Melinkeri, Sameer
    Santra, Manas Kumar
    Kale, Vaijayanti
    Limaye, Lalita
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [33] In vitro priming of normal donor PBMC with myeloma protein pulsed dendritic cells.
    Kim, SB
    Baskar, S
    Kwak, LW
    BLOOD, 2000, 96 (11) : 166A - 166A
  • [34] Idiotype-specific T cells in multiple myeloma: Targets for an immunotherapeutic intervention?
    Yi, Q
    Osterborg, A
    MEDICAL ONCOLOGY, 1996, 13 (01) : 1 - 7
  • [35] Immunotherapy of cancer - Generation of CEA specific CTL using CEA peptide pulsed dendritic cells
    Alters, SE
    Gadea, JR
    Philip, R
    DENDRITIC CELLS IN FUNDAMENTAL AND CLINICAL IMMUNOLOGY, VOL 3, 1997, 417 : 519 - 524
  • [36] A study of in vivo tracking of MUC-1 pulsed dendritic cells in patients with multiple myeloma
    Mileshkin, LR
    Wall, DM
    Loveland, BE
    Thompson, M
    Coverdale, J
    Wong, J
    Xing, PX
    Taylor, RR
    Hicks, RJ
    Prince, HM
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S27 - S27
  • [37] Dendritic cells and plasma cells from patients with myeloma as antigen presenting cells.
    Brown, R
    Pope, B
    Gibson, J
    Hart, D
    Joshua, D
    BLOOD, 1998, 92 (10) : 716A - 716A
  • [38] Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.
    Liso, A
    Stockerl-Goldstein, KE
    Aufferman, S
    Benike, CJ
    Reichardt, V
    van Beckhoven, A
    Rajapaksa, R
    Engleman, EG
    Blume, KG
    Levy, R
    BLOOD, 1999, 94 (10) : 715A - 715A
  • [39] Vaccination of melanoma patients with peptide-pulsed dendritic cells.
    Nestle, FO
    Gilliet, M
    Alijagic, S
    Grabbe, S
    Dummer, R
    Burg, G
    Schadendorf, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 404 - 404
  • [40] Phase I/II trial of immunotherapy with idiotype-loaded autologous dendritic cells (APC8020) for refractory multiple myeloma.
    MacKenzie, M
    Strang, G
    Peshwa, M
    Sopapan, J
    Valone, F
    BLOOD, 1998, 92 (10) : 108A - 108A
12345